Capillary Biomolecule Purification via Magnetic Bead Flow
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biochemistry sample purification methods, such as spin columns and paramagnetic bead-based purification, are labor-intensive, difficult to automate, and result in high reagent costs due to the need for multiple centrifugation steps and pipetting, which limits the efficiency and throughput of biomolecule isolation and processing.
Innovation Solution
A continuous flow capillary-based system using paramagnetic beads and a magnetic field for biomolecule isolation, where a slug of beads and sample flow through a conduit with controlled temperature zones, allowing for efficient binding, washing, and elution of target biomolecules without the need for manual pipetting, reducing reagent consumption and increasing automation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If paramagnetic bead-based purification is used, then DNA recovery rates are improved, but the process becomes labor-intensive and difficult to automate due to multiple pipetting steps
Solution Approach 1:
The patent uses a continuous flow liquid handling system where buffers and bead suspensions are pumped through a microfluidic chip containing magnetic beads. This hydraulic approach replaces manual pipetting with automated pumping, enabling high-throughput purification while maintaining DNA recovery rates. The system uses peristaltic or syringe pumps to control fluid flow through channels where magnetic beads are immobilized during binding and washing, then elute DNA in a continuous manner.
Solution Approach 2:
The patent replaces the mechanical pipetting process with an automated liquid handling system using magnetic fields for bead manipulation. Instead of mechanical pipette tips physically transferring liquids, the system uses magnetic actuators to hold, release, and transport magnetic beads through fluid channels, substituting mechanical pipetting with a combination of magnetic and hydraulic control for automated processing.
2Reliability
If multiple centrifugation steps are used in spin column purification, then sample purification is achieved, but the process cannot be integrated with automated DNA library preparation platforms
Solution Approach 1:
The patent replaces centrifugation-based spin column purification with a continuous flow liquid handling system using microfluidic channels and magnetic bead manipulation. Buffers flow through channels containing immobilized magnetic beads, allowing binding, washing, and elution steps to occur in a continuous hydraulic process rather than discrete centrifugation steps, enabling seamless integration with automated DNA library preparation platforms.
Solution Approach 2:
The patent extracts the purification function from the traditional spin column centrifugation system and implements it as a separate magnetic bead-based continuous flow module. This extraction allows the purification step to be independently optimized and integrated into automated workflows without requiring centrifugation equipment, simplifying the overall system architecture for automated DNA library preparation.
3Reliability
If a static well batch process is used for paramagnetic bead purification, then DNA binding to beads can be achieved, but large initial and final sample volumes result in high reagent costs
Solution Approach 1:
The patent uses a continuous flow liquid handling system where buffers and bead suspensions are pumped through microfluidic channels at controlled flow rates. This hydraulic approach enables precise control of buffer volumes and contact times, reducing reagent consumption compared to static well batch processes while maintaining DNA binding efficiency through optimized flow dynamics and residence time in the microfluidic channels.
Solution Approach 2:
The patent transitions from a two-dimensional static well format to a three-dimensional continuous flow system through microfluidic channels. This dimensional change allows for streamlined buffer paths, reduced dead volumes, and more efficient mass transfer between buffers and magnetic beads, reducing the total volume of reagents required while maintaining binding efficiency.
4Reliability
If multiple pipetting steps are performed, then sample purification can be completed, but the number of steps increases labor intensity and processing time
Solution Approach 1:
The patent replaces multiple discrete pipetting steps with a continuous flow liquid handling system using automated pumps and microfluidic channels. Buffers are continuously pumped through the system, performing binding, washing, and elution in sequence without manual intervention, dramatically increasing processing throughput while ensuring complete purification through controlled flow parameters and residence times.
Solution Approach 2:
The patent implements continuous flow processing where buffers and bead suspensions flow continuously through the microfluidic system, performing purification functions without interruption. This continuous action eliminates the start-stop nature of manual pipetting, maintaining constant processing velocity and enabling high-throughput operation while completing all necessary purification steps through optimized continuous flow paths.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The capillary-based system enables contamination-free, low-volume, high-throughput, and cost-effective biomolecule purification, improving recovery rates and reducing variability, as demonstrated by comparable DNA recovery rates and efficient removal of contaminants in next-generation sequencing applications.
Implementation Method 1
a magnetic field source configured to apply a magnetic field at the trapping site
Implementation Method 2
a heating element configured to apply heat to the conduit at the trapping site
Data Source
AI summary
Methods, devices and systems for handling sample liquids, encapsulating liquids and magnetic particles are disclosed.